This study investigates pancreatic cancer. It focuses on individuals who are at a higher risk of developing this condition due to family history, genetic mutations, or specific pancreatic cysts.
The study evaluates the safety and effectiveness of collecting and analyzing biospecimens from participants. This will help in understanding potential biomarkers for pancreatic cancer.
- Who can participate: Adults aged 18 and older with a strong family history of pancreatic cancer or specific genetic mutations may participate. Those with high-risk pancreatic cysts are also eligible.
- Study details: Participants will provide blood samples and complete questionnaires. Medical records will be reviewed, and pancreatic cyst fluid may be collected during standard procedures. A placebo is not involved in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand